Clinical Research Directory
Browse clinical research sites, groups, and studies.
EndoVascular Aortic Dissection Early vs Delayed
Sponsor: Shanghai Zhongshan Hospital
Summary
This is a prospective, multicenter, non-inferior, parallel-controlled observational study. This study aims to compare clinical outcomes of endovascular treatment for acute high-risk type B aortic dissection in the acute phase versus the subacute phase. No interventions will be imposed on the patients' standard treatment. Patients with acute high-risk type B aortic dissection will be grouped based on the actual timing of their treatment.
Official title: Endovascular Treatment for Acute High-risk Type B Aortic Dissection in Acute VS Subacute Phase: a Prospective, Multicenter, Non-inferior, Parallel Controlled Trial
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
4068
Start Date
2025-07-01
Completion Date
2030-07-31
Last Updated
2025-08-27
Healthy Volunteers
No
Conditions
Interventions
Acute Phase
Patients with acute high-risk type B aortic dissection received endovascular treatment in acute phase (2-14days)
Subacute Phase
Patients with acute high-risk type B aortic dissection received endovascular treatment in subacute phase (≥14days)
Locations (1)
Shanghai Zhongshan Hospital
Shanghai, China